Frank Magliochetti is a veteran healtcare executive, investment banker, and operator with over 40 years of experience creating, scaling, and exiting high-impact businesses in the medical, pharmaceutical, and healthcare services sectors.
He has led strategic growth initiatives for both Fortune 500 companies and private ventures—generating over $2 billion in cumulative enterprise value through turnarounds, acquisitions, and exits.
Frank’s leadership background includes senior roles at Baxter International, Haemonetics Corporation, and Sandoz Pharma (now Novartis). As co-founder and former President of one of the largest Medicare nursing and infusion therapy providers in the U.S., he grew the company to national scale. He also led Orthorehab to a 52x investor return in just 30 months, resulting in a highly successful acquisition.
Currently, Frank is CEO of Genetics Institute of America, a cutting-edge diagnostics lab specializing in oncology and pharmacogenomics. His depth in M&A execution, scalable healthcare operations, and capital markets strategy positions our team to build a best-in-class, acquisition-driven med spa platform—with clear appeal to private equity or public markets.
Alex Clug is a global entrepreneur, investor, and operator with a proven track record of building companies from the ground up to multi-billion-dollar valuations and public market exits.
A graduate of West Point and UCLA Anderson School of Management, Alex has led ventures across healthcare, fintech, natural resources, and emerging markets. Most notably, he played a pivotal role in taking SS Innovations International(Nasdaq: SSII) public—helping the medical robotics company reach a $1B+ market cap.
Previously, he helped lead Secure Fortress Plc in the UK to a 20x valuation increase in under 6 months, and scaled a telecom startup in Venezuela from launch to over 6,000 employees.
He’s held CEO, CFO, and COO positions in a range of companies—managing complex M&A across Latin America with Puntocom Holdings and Visa International, and launching a successful gold mining operation in Peru.
Alex brings world-class expertise in growth-stage strategy, cross-border capital structuring, and public market readiness—critical components of our vision to scale and exit a high-margin med spa platform.
Joshua Browning is a U.S. Marine Corps veteran, acquisition entrepreneur, and Florida native with over a decade of success in high-performance sales, marketing, and business development.
As a Property NCO in the elite 4th ANGLICO unit, Josh oversaw over $60 million in critical U.S. military assets—developing a foundation in leadership, logistics, and operational discipline in both combat and domestic settings.
Following his service, Josh earned his degree from the University of Central Florida and excelled in leadership roles across real estate, construction, and consumer services—driving consistent revenue growth and leading top-producing teams.
A graduate of the Quantum Leap Advantage (QLA) program at Guthrie Castle and Keller Williams’ BOLD Program, Josh combines strategic execution with a clear vision: to build Parula Medical Aesthetics into a dominant, acquisition-led med spa platform—focused on profitability, operational upgrades, and a clear exit pathway via private equity or IPO.